These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 31570311)

  • 1. A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study.
    Cantaert T; Borand L; Kergoat L; Leng C; Ung S; In S; Peng Y; Phoeun C; Hing C; Taing CN; Saman M; Ong S; Mey C; Choeung R; Ly S; Dussart P; Bourhy H; Tarantola A
    Lancet Infect Dis; 2019 Dec; 19(12):1355-1362. PubMed ID: 31570311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.
    Kerdpanich P; Chanthavanich P; De Los Reyes MR; Lim J; Yu D; Ama MC; Mojares Z; Casula D; Arora AK; Pellegrini M
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006340. PubMed ID: 29874228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
    Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
    Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003-2014.
    Tarantola A; Ly S; Chan M; In S; Peng Y; Hing C; Taing CN; Phoen C; Ly S; Cauchemez S; Buchy P; Dussart P; Bourhy H; Mary JY
    Vaccine; 2019 Oct; 37 Suppl 1():A118-A127. PubMed ID: 30454946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5 years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines.
    Quiambao BP; Ambas C; Diego S; Bosch Castells V; Korejwo J; Petit C; Rasuli A; Houillon G
    Vaccine; 2020 May; 38(21):3740-3746. PubMed ID: 32280042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India.
    Sudarshan MK; Narayana DH; Madhusudana SN; Holla R; Ashwin BY; Gangaboraiah B; Ravish HS
    Hum Vaccin Immunother; 2012 Aug; 8(8):1077-81. PubMed ID: 22699446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines.
    Quiambao BP; Ambas C; Diego S; Bosch Castells V; Korejwo J; Petit C; Houillon G
    Vaccine; 2019 Apr; 37(16):2268-2277. PubMed ID: 30890382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postexposure rabies prophylaxis completed in 1 week: preliminary study.
    Shantavasinkul P; Tantawichien T; Wilde H; Sawangvaree A; Kumchat A; Ruksaket N; Lohsoonthorn V; Khawplod P; Tantawichien T
    Clin Infect Dis; 2010 Jan; 50(1):56-60. PubMed ID: 19995217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
    Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
    Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabies post-exposure vaccination in 2 visits within a week: A 4-site intradermal regimen.
    Warrell MJ
    Vaccine; 2019 Feb; 37(9):1131-1136. PubMed ID: 30691982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabies Vaccine and Rabies Immunoglobulin in Cambodia: Use and Obstacles to Use.
    Tarantola A; Ly S; In S; Ong S; Peng Y; Heng N; Buchy P
    J Travel Med; 2015; 22(5):348-52. PubMed ID: 26173470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure.
    Warrell MJ
    Travel Med Infect Dis; 2012 Jan; 10(1):1-15. PubMed ID: 22342356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Immunogenicity and Safety Trial of 2 Different Schedules of Single-visit Intradermal Rabies Postexposure Vaccination.
    Soentjens P; De Koninck K; Tsoumanis A; Herssens N; Van Den Bossche D; Terryn S; Van Gucht S; Van Damme P; Van Herrewege Y; Bottieau E
    Clin Infect Dis; 2019 Aug; 69(5):797-804. PubMed ID: 30566636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study.
    WHO Rabies Modelling Consortium
    Lancet Infect Dis; 2019 Jan; 19(1):102-111. PubMed ID: 30472178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis.
    Ravish HS; Vijayashankar V; Madhusudana SN; Sudarshan MK; Narayana DH; Andanaiah G; Ashwin BY; Rachana AR; Shamanna M
    Hum Vaccin Immunother; 2014; 10(8):2433-7. PubMed ID: 25424951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess immunogenicity and safety.
    Quiambao BP; Lim JG; Bosch Castells V; Augard C; Petit C; Bravo C; Delore V; Houillon G
    Vaccine; 2022 Aug; 40(36):5347-5355. PubMed ID: 35933278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals.
    Madhusudana SN; Anand NP; Shamsundar R
    Int J Infect Dis; 2002 Sep; 6(3):210-4. PubMed ID: 12718837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.